PIVKA‑II is Associated with Liver Function, Bone Metabolism, and Muscle Function in Patients with Liver Disease

Overview

Journal Biomed Rep

Specialty Biochemistry

Date 2024 Jan 15

PMID 38222867

Authors

Takuya Honda

Tatsuki Ichikawa

Mio Yamashima

Shinobu Yamamichi

Makiko Koike

Yusuke Nakano

Tetsurou Honda

Hiroyuki Yajima

Osamu Miyazaki

Yasutaka Kuribayashi

Tomonari Ikeda

Takuma Okamura

Kazuyoshi Nagata

Kazuhiko Nakao

Affiliations

Soon will be listed here.

Abstract

Protein induced by vitamin K (VK) absence-II (PIVKA-II) is a sensitive marker for diagnosing hepatoma but is occasionally detected in patients without hepatoma Here, the clinical significance of serum PIVKA-II levels in patients who were not administered warfarin and did not have hepatoma or liver disease were evaluated. As VK is related to muscle and bone metabolism, PIVKA-II and clinical factors related to bone and muscle were compared. A total of 441 patients with various liver diseases were evaluated. Of these, 236 patients were female. Clinical factors and anthropometric measurements were obtained for each participant during outpatient visits. Among the clinical factors, type I procollagen N-propeptide (P1NP), a low titer of undercarboxylated osteocalcin (ucOC), and 25(OH) vitamin D (VD) were used as bone metabolic markers, and SARC-F and grip strength were used as muscle-related markers. Serum PIVKA-II levels above the upper limit were associated with Child B/C (Child-Pugh score), high titers of total P1NP, and low titers of ucOC in females, and alcohol-related liver disease and low VD in males. The titer of PIVKA-II were associated with immunoglobulin (Ig) A and prothrombin time (PT)-international normalized ratio (INR) in females, and fibrosis-4-4, IgG, total bilirubin, PT-INR, and SARC-F in males. Elevated PIVKA-II levels were associated with abnormal bone physiology in females, weak muscles in males, and severe liver disease in both sexes. Assessing PIVKA-II may assist in evaluating the clinical and bone-muscle metabolic stages in liver disease. Nutrition and supplementation with fat-soluble vitamins, including VK and VD may thus serve as a potential method to alleviate or prevent bone-muscle pathophysiology in patients with liver disease.

References

Nishikawa H, Shiraki M, Hiramatsu A, Moriya K, Hino K, Nishiguchi S . Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria. Hepatol Res. 2016; 46(10):951-63. DOI: 10.1111/hepr.12774. View

Kamath P, Wiesner R, Malinchoc M, Kremers W, Therneau T, Kosberg C . A model to predict survival in patients with end-stage liver disease. Hepatology. 2001; 33(2):464-70. DOI: 10.1053/jhep.2001.22172. View

Lin X, Brennan-Speranza T, Levinger I, Yeap B . Undercarboxylated Osteocalcin: Experimental and Human Evidence for a Role in Glucose Homeostasis and Muscle Regulation of Insulin Sensitivity. Nutrients. 2018; 10(7). PMC: 6073619. DOI: 10.3390/nu10070847. View

Kim S, Jung H, Kim C, Kim K, Chin H, Lee H . A New Equation to Estimate Muscle Mass from Creatinine and Cystatin C. PLoS One. 2016; 11(2):e0148495. PMC: 4744004. DOI: 10.1371/journal.pone.0148495. View

Yan C, Hu J, Yang J, Chen Z, Li H, Wei L . Serum ARCHITECT PIVKA-II reference interval in healthy Chinese adults: Sub-analysis from a prospective multicenter study. Clin Biochem. 2018; 54:32-36. DOI: 10.1016/j.clinbiochem.2018.02.007. View

Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V . FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology. 2007; 46(1):32-6. DOI: 10.1002/hep.21669. View

Binkley N, Buehring B . Beyond FRAX: it's time to consider "sarco-osteopenia". J Clin Densitom. 2009; 12(4):413-6. DOI: 10.1016/j.jocd.2009.06.004. View

Child C, Turcotte J . Surgery and portal hypertension. Major Probl Clin Surg. 1964; 1:1-85. View

Niezen S, Tapper E, Trivedi H, Lai M, Curry M, Mukamal K . Prevalence of High Liver Stiffness and a Screening Strategy Using the SODA-2B Score Among US Adults. Hepatol Commun. 2021; 6(4):898-909. PMC: 8948660. DOI: 10.1002/hep4.1837. View

10.

Lee S, Jo H, Kim M, Kim J, You Y . Association between osteocalcin and metabolic syndrome in postmenopausal women. Arch Gynecol Obstet. 2015; 292(3):673-81. DOI: 10.1007/s00404-015-3656-7. View

11.

Kuwabara A, Fujii M, Kawai N, Tozawa K, Kido S, Tanaka K . Bone is more susceptible to vitamin K deficiency than liver in the institutionalized elderly. Asia Pac J Clin Nutr. 2011; 20(1):50-5. View

12.

Ozaki D, Kubota R, Maeno T, Abdelhakim M, Hitosugi N . Association between gut microbiota, bone metabolism, and fracture risk in postmenopausal Japanese women. Osteoporos Int. 2020; 32(1):145-156. PMC: 7755620. DOI: 10.1007/s00198-020-05728-y. View

13.

Taura N, Ichikawa T, Miyaaki H, Ozawa E, Tsutsumi T, Tsuruta S . Frequency of elevated biomarkers in patients with cryptogenic hepatocellular carcinoma. Med Sci Monit. 2013; 19:742-50. PMC: 3775616. DOI: 10.12659/MSM.889361. View

14.

Rodrigues F, Ormanji M, Heilberg I, Bakker S, de Borst M . Interplay between gut microbiota, bone health and vascular calcification in chronic kidney disease. Eur J Clin Invest. 2021; 51(9):e13588. PMC: 8459296. DOI: 10.1111/eci.13588. View

15.

Ichikawa T, Miyaaki H, Miuma S, Motoyoshi Y, Yamashima M, Yamamichi S . Indices calculated by serum creatinine and cystatin C as predictors of liver damage, muscle strength and sarcopenia in liver disease. Biomed Rep. 2020; 12(3):89-98. PMC: 7006091. DOI: 10.3892/br.2020.1273. View

16.

van Ballegooijen A, Beulens J, Kieneker L, de Borst M, Gansevoort R, Kema I . Combined low vitamin D and K status amplifies mortality risk: a prospective study. Eur J Nutr. 2020; 60(3):1645-1654. PMC: 7987611. DOI: 10.1007/s00394-020-02352-8. View

17.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

18.

Hayashi M, Yamada S, Takano N, Okamura Y, Takami H, Inokawa Y . Different Characteristics of Serum Alfa Fetoprotein and Serum Des-gamma-carboxy Prothrombin in Resected Hepatocellular Carcinoma. In Vivo. 2021; 35(3):1749-1760. PMC: 8193278. DOI: 10.21873/invivo.12434. View

19.

Wester A, Ndegwa N, Hagstrom H . Risk of Fractures and Subsequent Mortality in Alcohol-Related Cirrhosis: A Nationwide Population-Based Cohort Study. Clin Gastroenterol Hepatol. 2022; 21(5):1271-1280.e7. DOI: 10.1016/j.cgh.2022.05.048. View

20.

Xia M, Rong S, Zhu X, Yan H, Chang X, Sun X . Osteocalcin and Non-Alcoholic Fatty Liver Disease: Lessons From Two Population-Based Cohorts and Animal Models. J Bone Miner Res. 2020; 36(4):712-728. DOI: 10.1002/jbmr.4227. View